Nanjing Acolmmune Biopharma was founded by Professor Liu Yang, an internationally renowned immunologist, fellow of the American Association for the Advancement of Science and founder of OncoImmune Inc. In 2017 and 2018, Suzhou Acolmmune Biopharma Technology Co., Ltd. and Guangzhou Acolmmune Biopharma  Co., Ltd. were established respectively in Suzhou Industrial Park and Guangzhou International Biological Island. The group is committed to developing innovative immunotherapy drugs, focusing on the immunotherapy of malignant tumors and inflammatory diseases. At present, the company has a number of Best in Class and First in Class original new drug products.